Funding Raises Questions Of FDA's Authority

02/19/2002 | Seattle Times, The

Funding from the drug industry has paid for quick reviews and more approvals by the FDA. Current law, which limits access to taxpayer dollars, is set to expire in September and would leave the agency without primary funding to carry out drug approval and long-term safety monitoring.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
Winston-Salem, NC